| 28th Sep 2020 7:00 am |
RNS |
ANGLE announces completion of FDA submission |
| 23rd Sep 2020 7:00 am |
RNS |
Potential treatment strategy to limit metastasis |
| 11th Sep 2020 3:35 pm |
RNS |
Holding(s) in Company |
| 11th Sep 2020 3:30 pm |
RNS |
Holding(s) in Company |
| 2nd Sep 2020 1:49 pm |
RNS |
Notification of Interim Results and Webcast |
| 2nd Sep 2020 10:00 am |
RNS |
Holding(s) in Company |
| 27th Aug 2020 3:13 pm |
RNS |
Result of 2020 Annual General Meeting |
| 18th Aug 2020 9:30 am |
RNS |
Holding(s) in Company |
| 14th Aug 2020 7:00 am |
RNS |
Parsortix use to assess response to immunotherapy |
| 6th Aug 2020 12:20 pm |
RNS |
Holding(s) in Company |
| 5th Aug 2020 7:00 am |
RNS |
Notice of AGM and Posting of Annual Report |
| 20th Jul 2020 7:00 am |
RNS |
Study: Parsortix use in metastatic breast cancer |
| 8th Jul 2020 5:35 pm |
RNS |
Holding(s) in Company |
| 8th Jul 2020 5:30 pm |
RNS |
Holding(s) in Company |
| 8th Jul 2020 5:30 pm |
RNS |
Holding(s) in Company |
| 25th Jun 2020 7:00 am |
RNS |
Preliminary Results |
| 22nd Jun 2020 7:00 am |
RNS |
Blood donations recommenced for FDA studies |
| 29th May 2020 7:00 am |
RNS |
Notice of Results |
| 12th May 2020 7:00 am |
RNS |
CTC potential as biomarker in MET inhibitor trials |
| 4th May 2020 7:00 am |
RNS |
Leading cancer centre publishes Parsortix workflow |
| 28th Apr 2020 7:00 am |
RNS |
Business Update |
| 17th Apr 2020 7:00 am |
RNS |
Parsortix performance in head and neck cancer |
| 3rd Mar 2020 7:00 am |
RNS |
Assessing risk of brain metastasis in lung cancer |
| 27th Feb 2020 7:00 am |
RNS |
Parsortix outperforms other CTC systems in RCC |
| 25th Feb 2020 7:00 am |
RNS |
ANGLE announce Tri-Con presentation with BioView |
| 17th Feb 2020 7:00 am |
RNS |
Data demonstrates key advantages of Parsortix |
| 11th Feb 2020 7:00 am |
RNS |
Study demonstrates Parsortix potential in melanoma |
| 3rd Feb 2020 9:10 am |
RNS |
Issue of Equity |
| 30th Jan 2020 7:00 am |
RNS |
Interim Results |
| 30th Jan 2020 7:00 am |
RNS |
Change of accounting reference date |
| 22nd Jan 2020 7:00 am |
RNS |
Successful face-to-face meeting with FDA |
| 8th Jan 2020 12:33 pm |
RNS |
Notice of Results |
| 23rd Dec 2019 9:55 am |
RNS |
Issue of Equity |
| 7th Nov 2019 7:00 am |
RNS |
Cancer centre shows Parsortix use in melanoma |
| 30th Oct 2019 2:44 pm |
RNS |
Result of AGM |
| 30th Oct 2019 7:00 am |
RNS |
Q-submission to FDA containing headline data |
| 8th Oct 2019 7:00 am |
RNS |
Notice of AGM |
| 4th Oct 2019 5:54 pm |
RNS |
Holding(s) in Company |
| 4th Oct 2019 7:00 am |
RNS |
European patent granted for megakaryocyte analysis |
| 13th Sep 2019 7:00 am |
RNS |
Use of Parsortix in head and neck cancer |
